GordonMD Global Investments LP

CIK

2039349

Location

Beverely Hills, CA

Portfolio Value

Small $156,929,309

Diversification

Diversified

Filing Date

Global Rank

#4,404 / 8,232 ▲ 521

Top Industry

Biotechnology 65.5%

3Y Alpha vs SPY

-7.3%

Period ended 2 months ago

Filed May 15, 2026 · 30d

2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+7.1%

SPY

+9.1%

Annualised alpha

-7.3%

Max drawdown

−16.5%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

16 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

24.1%

−5.5 pts

Top 5

66.5%

−0.8 pts

Top 10

85.3%

−4.5 pts

HHI

1,365

Diversified−88

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$156,929,309	16

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

2 positions

Ticker	Company	Δ Shares	Shares	Value
VIR	Vir Biotechnology, Inc.	+588,235	1,518,552	$13,606,225
TEVA	Teva Pharmaceutical Industries Ltd	+487,945	1,257,495	$37,875,749
No positions match the current search.

Trimmed

Positions the filer reduced

8 positions

Ticker	Company	Δ Shares	Shares	Value
TSHA	Taysha Gene Therapies, Inc.	−593,351	737,550	$3,296,848
KYTX	Kyverna Therapeutics, Inc.	−147,000	4,244,818	$36,632,779
CRNX	Crinetics Pharmaceuticals, Inc.	−97,150	126,985	$4,612,095
RARE	Ultragenyx Pharmaceutical Inc.	−40,000	289,101	$6,056,665
BLCO	Bausch & Lomb Corp	−40,000	573,472	$9,118,204
TARS	Tarsus Pharmaceuticals, Inc.	−24,000	42,680	$2,994,002
INCY	Incyte Corp	−11,200	43,300	$4,075,396
AMGN	Amgen Inc	−3,000	20,212	$7,111,592
No positions match the current search.

New Positions

Positions the filer opened this quarter

3 positions

Ticker	Company	Shares	Value
SRRK	Scholar Rock Holding Corp	132,500	$6,513,700
SION	Sionna Therapeutics, Inc.	136,000	$5,452,240
ALLO	Allogene Therapeutics, Inc.	1,430,000	$3,489,200
No positions match the current search.

Sold Out

Positions the filer fully exited

No qualifying positions this quarter.

Portfolio Positions

Compact Export CSV View 13F filing

16 positions · $156,929,309 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
TEVA	Teva Pharmaceutical Industries Ltd Healthcare	Added	1,257,495	+487,945	$37,875,749	+57.7%	24.14%
KYTX	Kyverna Therapeutics, Inc. Healthcare	Reduced	4,244,818	-147,000	$36,632,779	−11.3%	23.34%
VIR	Vir Biotechnology, Inc. Healthcare	Added	1,518,552	+588,235	$13,606,225	+142.5%	8.67%
BLCO	Bausch & Lomb Corp Healthcare	Reduced	573,472	-40,000	$9,118,204	−13.0%	5.81%
AMGN	Amgen Inc Healthcare	Reduced	20,212	-3,000	$7,111,592	−6.4%	4.53%
SRRK	Scholar Rock Holding Corp Healthcare	NEW	132,500	NEW	$6,513,700	NEW	4.15%
RARE	Ultragenyx Pharmaceutical Inc. Healthcare	Reduced	289,101	-40,000	$6,056,665	−20.0%	3.86%
PYXS	Pyxis Oncology, Inc. Healthcare	Held	4,121,870	0	$6,017,930	+27.0%	3.83%
SION	Sionna Therapeutics, Inc. Healthcare	NEW	136,000	NEW	$5,452,240	NEW	3.47%
CLDX	Celldex Therapeutics, Inc. Healthcare	Held	170,307	0	$5,402,138	+16.8%	3.44%
INSM	INSMED Inc Healthcare	Held	28,587	0	$4,674,546	−6.0%	2.98%
CRNX	Crinetics Pharmaceuticals, Inc. Healthcare	Reduced	126,985	-97,150	$4,612,095	−55.8%	2.94%
INCY	Incyte Corp Healthcare	Reduced	43,300	-11,200	$4,075,396	−24.3%	2.60%
ALLO	Allogene Therapeutics, Inc. Healthcare	NEW	1,430,000	NEW	$3,489,200	NEW	2.22%
TSHA	Taysha Gene Therapies, Inc. Healthcare	Reduced	737,550	-593,351	$3,296,848	−55.0%	2.10%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	Reduced	42,680	-24,000	$2,994,002	−45.2%	1.91%